Your institution may have access to this item. Find your institution then sign in to continue.
Title
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31.
Authors
Perez, Edith A.; Romond, Edward H.; Suman, Vera J.; Jeong, Jong-Hyeon; Davidson, Nancy E.; Geyer Jr, Charles E.; Wolmark, Norman; Martino, Silvana; Mamounas, Eleftherios P.; Kaufman, Peter A.
Publication
Journal of Clinical Oncology, 2011, Vol 29, Issue 25, p3366